-
Polycab (-ve): Block deal likely, promoters to sell 0.8% stake worth ₹887 cr at floor ₹7300 (3% discount).
-
Glenmark (+ve): Ties up with Hengrui for cancer therapy; deal worth up to $1.093 bn.
-
Polymedicure (+ve): Acquires Citieffe (Italy) for ₹324 cr; boosts global orthopaedics presence.
-
Dr. Reddy’s (+ve): To sell generic HIV drug at $40/year vs branded $28k in US.
-
Lupin (+ve): Gets USFDA tentative nod for HIV treatment drug.
-
Piramal Enterprises (+ve): NCLT clears merger with Piramal Finance.
-
Tata Motors (+ve): UK govt may buy/sell JLR supplier parts to aid production.
-
ONGC, Oil India (+ve): Benefit from Brent’s 7-week high.
-
Hind Copper (+ve): LME copper up 3% after Freeport force majeure.
-
IPCA Labs (+ve): Biosimilar tech transfer strengthens US presence.
-
Rajesh Exports, Vaibhav Global (-ve): Jewellery imports restricted till March.
-
Apeejay Surendra Park (+ve): Acquires Zillion Hotels (Mumbai) for ₹207 cr.
-
LT Foods, KRBL (+ve): Govt mandates registration for non-basmati exports; KRBL also alters MoA.
-
TBO Tek (+ve): Partners Amadeus for South Asia travel marketplace.
🔎 Stocks to Watch
—
by